Malignant mesothelioma

Current Diagnostic Pathology

Volumn 3, Issue 3, 1996, Pages 153-164

  Hasleton, P S ^a   Hammar, S P ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000460815     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(05)80013-4     Document Type: Article

References (123)

1. Peto J, Hodgson J T, Matthews P E, Jones J R. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535-539.
2. Spirtas R, Beebe G W, Connelly R R et al. Recent trends in mesothelioma incidence in the United States. Am J Ind Med 1986; 9: 397-407.
3. Berry G. Epidemiology of mesothelioma. In: Tattersall M, ed. Preventing Cancer. Sydney Australian Professional Publications, 1988; 35-(4.
4. Peto J, Henderson B E, Pike M C. Trends in mesothelioma incidence in the United States and the forecast epidemic due to asbestos exposure during World War II. In: Peto J, Schneiderman M, eds. Banbury Report 9. Quantification of Occupational Cancer. New York: Cold Spring Harbor Laboratory, 1981,51-73.
5. McDonald J C. Health implications of environmental exposure to asbestos. Environ Health Perspect 1985; 62:319-328.
6. Wagner J C, Sleggs C A, Marchand P. Diffuse pleural mesotheliomas and asbestos exposure in a north western Cape Province. Br J Ind Med 1960; 17: 260-271.
7. Wagner J C. The discovery of the association between blue asbestos as mesotheliomas and the aftermath. Br J Ind Med 1991;48:399-403.
8. Henderson D W, Shilkin K B, Langlois S, Le P, Whitaker D. Malignant mesothelioma. New York: Hemisphere Publishing Corp., 1992.
9. Gibbs A R. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax 1990; 45: 649-654.
10. Stayner L T, Danovic D A, Lernen RA. Occupational exposure to chrysotile asbestos and cancer risk; a review of the amphibole hypothesis. Am J Pub Health 1996; 186: 158-159, 186: 179-186.
11. Webster I. Asbestos and malignancy. S Afr Med J. 1973; 47: 165-171.
12. Churg A. Chrysotile, tremolite and malignant mesothelioma in man. Chest 1988; 93: 621-628
13. Baris Y I, Artvinli M, Sahin A A, Bilir N, Kalyoncu F, Sebastien. Non-occupational asbestos-related chest diseases in a small Anatolian village. Br J Ind Med 1988; 45: 841-842.
14. Berry G, Wagner J C. The application of a mathematical model describing the times and occurence of mesotheliomas in rats following inocculation with asbestos. Br J Cancer 1969; 23:582-586.
15. Selikoff I C, Hammond E C, Seidman H. Latency of asbestos disease among asbestos workers in the United States and Canada. Cancer 1980; 46: 2735-2740.
16. Selikoff IJ, Hammond E C. Asbestos and smoking. JAMA 1979; 242:458-459.
17. Key F, Viallet J R, Farisse P, Boulin C. Pleural migration of asbestos fibres after intratracheal injection in rats. Eur Respir Rev 1993; 11: 145-147.
18. Mossman B T. Mechanisms of asbestos carcinogenesis and toxicity. The amphibole hypothesis revisited. Br J Ind Med 1993; SO: 673-676.
19. Waldren C A. Mutational analysis in cultured human hamster hybrid cell: In deSorres F J ed: Chemical Mutagens: Principles and Methods for Their Detection. New York: Plenum Press; 1983:235-237.
20. Lund A G, Aust A E. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in OX174 FRI DNA. Carcinogenesis 1992; 13:637-664.
21. Lechner J F, Tokiwa T, La Veck M et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sei USA 1985; 82: 3884-3888.
22. Heinz N H, Jansen Y M, Mossman V T. Persistent induction of C-fos and C-Jun protooncogenes expression by asbestos. Proc Natl Acad Sei USA. 1993; 90: 3299-3303.
23. Hasleton P S. Pleural Disease. In: Spencer's Pathology of the Lung. New York: McGraw Hill, 1996: 1154-1210.
24. Hunchareck M. Miliary mesothelioma. Chest 1994; 106:605-606.
25. Butchart E G, Ashcroft T, Bamsley W C, Holden M P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976; 31: 15-24.
26. Craighead J E, Abraham J L, Churg A et al. The pathology of asbestos associated disease of the lungs and pleural cavities. Report of the Pneumoconiosis Committee of the American College of Pathologists and National Institute of Occupational Safety and Health. Arch Pathol Lab Med 1982; 106:544-596.
27. Jones J S P. Pathology of the Mesothelium, London: SpringerVerlag, 1988.
28. Roggli V L, Greenberg S D, Pratt P C. Pathology of asbestosassociated diseases. Boston: Little Brown, 1992.
29. Histological Typing of Lung Tumours. Geneva: World Health Organisation, 1981.
30. Roggli V L, McGraven M H, Subach J, Sybers H D, Greenberg S D. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma. A study of 25 cases. Cancer 1982; 50:2423-2432.
31. Hillderdal G. Malignant mesothelioma, 1982. Review of 4710 published cases. Br J Dis Chest 1983; 77: 321-343.
32. Batlifora H, McCaughey W T E. Atlas of Tumour Pathology. Tumors of the Serosal Membranes 3rd series. Washington DC: Fascicle 15 Armed Forces Institute of Pathology, 1994: 31.
33. Goldstein B. Two malignant pleural mesotheliomas with unusual histological features. Thorax 1979; 34: 375-379.
34. Yousem S A, Hochholzer L. Malignant mesothelioma with osseous and cartilagenous differentiation. Arch Pathol Lab Med 1987; 111:62-66.
35. Wilson G E, Hasleton P S, Chatteijee A K. Desmoplastic diffuse mesothelioma. A review of 17 cases. J Clin Pathol 1992; 45:295-298.
36. Roggli V L, Kolbeck J, Sanfilippo F, Shelbume J D. Pathology of human mesothelioma. Etiologic and diagnostic considerations. Pathol Ann 1987; 22: (part 2) 91-131.
37. Mayall F G, Gibbs A R. The histology and immunohistochemistry of small cell mesothelioma. Histopathology 1992; 20:57-51.
38. Nascimento A G, Keeney G L, Fletcher C D. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol. 1994; 18: 439-445.
39. Towerman A, Montera J R, Chilcote R R, Okagaki T. Diffuse malignant peritoneal mesothelioma in a 13 year old girl. Report of a case and review of the literature. Am J Surg Pathol 1985; 9:73-80.
40. Elmes P C, Simpson M J C. The clinical aspects of mesothelioma. Quart J Med 1976; 179:427-U9.
41. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff I J. Malignant mesothelioma in a cohort of asbestos workers: clinical presentation, diagnosis and cause of death. Br J Indust Med 1988; 45: 182-187.
42. Sherman M E, Mark E J. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990; 114: 845-851.
43. Sridhar K S, Doria R, Raub W A, Thurer R J, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992; 70: 2969-2979.
44. Benjamin C J, Ritchie A C. Histological staining for the diagnosis of mesothelioma. Am J Med Technol 1982; 48:905-908.
45. Hammar S P, Bockus D E, Remington F L, Rohrbach K A. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical and ultrastructural comparison with mucin producing pulmonary adenocarcinomas. Ultra Pathol. In Press.
46. Hammar S P, Pleural diseases. In: Pulmonary Pathology, 2nd Ed. Dail D H, Hammar S P (Eds) New York, Springer-Verlag Ine, 1994; 1463-1580.
47. Henderson D W, Comin C F, Hammar S P, Shilkin K B, \Vhitaker D. Malignant mesothelioma of the pleura. Current Surgical Pathology. In Press.
48. Henderson D W, Shilkin K B, Whitaker D, Attwood H D, Constance T J, Steele R H, Leppard P J. The pathology of malignant mesothelioma including immunohistology and ultrastructure. In: Henderson D W, Shilkin K G, Langlois S L P, Whitaker D, eds. Malignant mesothelioma 1992; 69-132.
49. Blobel G A, Moll R, Franke W W, Kayser K W, Gould V E. The intermediate filament cytoskeleton of malignant mesothelioma and its diagnostic significance. Am J Pathol 1985; 12:235-247.
50. Moll R, Dhovailly D, Sun T. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AEI4. Virch Arch (B) Cell Pathol 1989; 58: 129-145.
51. Kahn H J, Hanna W, Yeger H, Baumal R. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions: comparison with intermediate filament distribution by electron microscopy. Am J Pathol 1982; 109: 206-214.
52. Kahn H J, Thorner P S, Yeger H, Bailey D, Baumal R. Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids and mesotheliomas using polyclonal and monoclonal antikeratin antibodies. Am J Clin Pathol 1986; 86: 566-574.
53. Churg A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 1985; 9: 360-365.
54. Mullink H, Henzen-Logmans S C, Alons-vanKordelaar J J M et al. Simultaneous immunoenzyme staining of vimentin and cytokeratin with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma. Virch Arch (B) Pathol Anat 1986; 42: 55-65.
55. Jasani B, Edwards R E, Thomas N D, Gibbs A R. The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virch Arch (A) Pathol Anat 1985; 406: 441-448.
56. Leong A S-Y, Parkinson R, Milios J. 'Thick' cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma. Diag Cytopathol 1990; 6: 9-13.
57. Sheibani K, Esteban J M, Bailey A, Battifora H, Weiss IM. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 1992; 23:107-116.
58. O'Hara C J, Corson J M, Pinkus G S, Stahel R A. M E 1: a monoclonal antibody that distinguishes epithelial type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. Am J Pathol 1990; 136: 421-428.
59. Sheibani K, Battifora H, Burke J. Antigenic phenotypc of malignant mesotheliomas and pulmonary adenocarcinomas: an immunohistologic analysis demonstrating the value of Leu Ml antigen. Am J Pathol 1986; 123: 212-219.
60. Szpak C A, Johnston W W, Roggli V et al. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3). Am J Pathol 1986; 122: 252-260.
61. Sheibani K, Shin S S, Kezirian J, Weiss L M. BerEP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma. Am J Surg Pathol 1991; 15:779-784.
62. Metzger J, Lamerz R. Permanetter W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorac Cardiovasc Surg 1990; 100: 860-866.
63. Corson J M, Pinkus G S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol 1982; 108: 80-87.
64. Otis C N, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. Am J Surg Pathol 1987; 11:445-456.
65. Gaffney M J, Mills S E, Swanson P E, Zarbo F J, Shah A R, Wick M R. Immunoreactivity for Ber EP4 in adenocarcinomas, adenomatoid tumors and malignant mesotheliomas. Am J Surg Pathol 1992; 16: 593-599.
66. Collins C L, Ordonez N G, Schaefer R et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992; 141: 827-833.
67. Fink L, Collins C L, Schaefer R, et al. Thrombomodulin expression can be used to differentiate between mesotheliomas and adenocarcinomas. Lab Invest 1992; 66: 113A.
68. Wick M R, Mills S E, Swanson P E. Expression of myelomonocytic antigens in mesotheliomas and adenocarcinomas involving the serosal surfaces. Am J Clin Pathol. 1990; 94: 18-26.
69. Lee I, Radosevich J A, Chejfec G et al. Malignant mesotheliomas: improved differential diagnosis from lung adenocarcinoma using monoclonal antibodies 44-3AG and 624A12. Am J Pathol 1986; 123: 497-507.
70. Spagnolo D V, Whitaker D, Carrello S et al. The use of monoclonal antibody 44-3AG in cell blocks in the diagnosis of lung carcinoma, carcinoma metastatic to lung and pleura and pleural malignant mesothelioma. Am J Clin Pathol 1991, 95: 322-329.
71. Solar A P, Knudsen K A, Jaurand M-C et al. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesothelioma from lung adenocarcinoma. Hum Pathol 1995; 26: 1363-1369.
72. Azumi N, Underhill C B, Kagan E, Sheibani K. A novel biotinylated probe specific for hyaluronate; its diagnostic value in diffuse malignant mesothelioma. Am J Surg Pathol 1992; 16:116-121.
73. Amin K M, Litzky L A, Smythe W R et al. Wilms tumor susceptibility (\VT) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995; 146: 344-356.
74. Okamoto H, Matsuno Y, Noguchi M et al. Malignant pleural mesothelioma producing chorionic gonadotrophin: report of two cases. Am J Surg Pathol 1992; 16: 969-974.
75. McAuley P, Asa S L, Chiu B, Henderson J, Goltzman D, Ducker D J. Parathyroid hormone-like peptide in normal and neoplastic mesothelial cells. Cancer 1990; 66: 1975-1979.
76. Hulimann J. Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol 1994; 25: 753-757.
77. Kung IT M, Thallas V, Spencer E J, Wilson S M. Expression of muscle actins in diffuse mesothelioma. Hum Pathol 1995; 26: 565-570.
78. Bolen J W, Hammar S P, McNutt M A. Reactive and neoplastic serosal tissue. A light microscopic, ultrastructural and immunocytochemical study. Am J Surg Pathol 1986; 10: 34-47.
79. Mittenen M. Immunohistochemistry of soft tissue tumors: possibilities and limitations in surgical pathology. Pathol Annu 1990; 25 (part 1)1-36.
80. Corrin B. Pulmonary adenocarcinoma mimicking epithelial mesothelioma. Ultra Pathol. In Press.
81. Dewar A, Valente M, Ring N P, Corrin B. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol 1987; 152: 309-316.
82. Coleman M, Henderson D W, Mukherjee T M. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu 1989; 24: 303-353.
83. Ghadially F N, McCaughey W T E, Perkins D G, Rippstein P. Diagnostic value of microvillous matrix association in tumors. J Submicrosc Cytol Pathol 1992; 24: 103-108.
84. Ghadially F N, McCaughey W T E, Perkins D G, Rippstein P, Jeans D. Morphogenesis and frequency of microvillous-matrix associations in mesotheliomas and adenocarcinoma. MSA Bulletin 1993; 23: 281-287.
85. Ghadially F N. Diagnostic value of some matrix components. Ultra Pathol 1992; 16: 221-230.
86. Croonen A M, van der Valk P, Herman C J, Linderman J. Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions. Lab Invest 1987; 58:"l20-126.
87. Hafiz M A, Becker R L, Jr Mikel U V, Bahr G F. Cytophotometric determination of DNA in mesothelioma and reactive mesothelial cells. Anal Quant Cytol Histol 1988; 58: 120-126.
88. Frierson H F, Mills S E, Legier J F. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant mesothelioma. Am J Clin Pathol 1988; 20: 240-243.
89. Burmer C G, Rabinovitch P S, Kulander B G, Rusch V, McNutt M A. Flow cytometric analysis of malignant pleural mesothelioma: relationship to histology and survival J Pathol 1989; 20:777-783.
90. Dazzi H, Thatcher N, Hasleton P S, Chatterjee A K, Lawson R A M. DNA analysis by flow cytometry in malignant pleural mesothelioma: relationship to histology and survival. J Pathol 1990; 162:51-55.
91. Tierney G, Wilkinson M J, Jones J S P. The malignancy grading method is not a reliable assessment of malignancy in mesothelioma. J Pathol 1990; 160: 209-211.
92. El-Naggar A K, Ordonez N G, Garnsey L, Barsakis J G. Epithelioid pleural mesotheliomas and pulmonary adenocarcinoma: a comparative DNA flow cytometric study. Hum Pathol 1991; 22: 972-978.
93. Esteban J M, Sheibani K. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinomas. Mod Pathol 1992; 6: 626-630.
94. Whitaker D, Manning L S, Robinson B W S, Shilkin K B. The Pathobiology of the Mesothelium. In: Henderson D W, Shilkin K B, Langlois S L P, Whitaker D, eds. Malignant mesothelioma. New York: Hemisphere, 1992: 25-68.
95. Tiainen M, Tammilethol L, Rautonen J, Tumoi T, Mattson K, Knoutila S. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma Br J Cancer 1989; 60: 618-626.
96. Hagemeijer A, Versnel M A, Van Drunen E et al. Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet 1990; 47: 1-28.
97. Renshaw A A, Dean B R, Antman K H, Sugarbaker D J, Cibas E S. The role of cytologie evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. In Press.
98. Rosai J, Dehner L P. Nodular mesothelial hyperplasia in hernia sacs: a benign reactive condition simulating a neoplastic process. Cancer 1975; 35: 165-175.
99. Brooks J S J, Li Volsi V A, Pietra G G. Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 1990; 93: 741-748.
100. Babolini G, Blasi A. The pleural form of primary cancer of the lung. Dis Chest 1956; 29: 314-323.
101. Harwood T R, Gracey D R, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol 1976; 65: 159-167.
102. Robb J A, Hammar S P, Yooko H. Pseudomesotheliomatous lung carcinoma: a rare asbestos related malignancy readily separable from epithelial pleural mesothelioma. Hum Pathol. In Press.
103. Koss M, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diag Pathol 1992; 9: 117-123.
104. Lin BT-Y, Colby T, Gown A M, Hammar S P, Mertens R B, Churg A, Battifora H. Malignant vascular tumors of the serous membranes mimicking mesothelioma: a report of 14 cases. Am J Surg Pathol. In Press.
105. Foyle A, Al-Jabi M, McCaughey W T E. Papillary peritoneal tumors in women. Am J Surg Pathol 1981; 5: 241-249.
106. Bollinger D J, Wick M R, Dehner L P et al. Peritoneal malignant mesotheliomas versus serous papillary adenocarcinoma: a histochemical and immunohistochemical comparison. Am J Surg Pathol 1989; 13:659-670.
107. Raju U, Fine G. Greenawald K A, Ohorodnik J M. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol 1989; 20: 424-436.
108. Khoury N, Raju U, Crissman J D et al. A comparative immunohistochemical study of peritoneal and ovarian serous tumors and mesotheliomas. Hum Pathol 1990; 21: 811-819.
109. Renshaw A A. 013 (CD99) in spindle cell tumors: reactivity in hemangiopericytoma, solitary fibrous tumor, synovial sarcoma and meningioma, but rarely with sarcomatoid mesothelioma. AppI Immunohistochem 1995; 3: 250-256.
110. McCaughey W T E, Kannerstein M, Churg J. Tumors and Pseudotumors of the Serous Membranes. Second Series. Fascicle 20. Washington DC: Armed Forces Institute of Pathology, 1985.
111. Crotty T B, Myers J L, Katzenstein A A, Tazelaar H D, Swensen S J, Churg A. Localized malignant mesothelioma: a clinicopathologic and flow cytometric study. Am J Surg Pathol 1994; 18:357-363.
112. Taylor D R, Page W, Hughes D, Varghese G. Metastatic renal cell carcinoma mimicking pleural mesothelioma. Thorax 1987:42:901-902.
113. Miettinen M, Franssila K. Immunohistologic spectrum of malignant melanoma: the common presence of keratins. Lab Invest 1989:61:623-628.
114. Gaertner E, Zeren E H, Fleming M V, Colby T V. Sarcomas arising in the pleural cavity: a clinicopathologic study of five cases. Am J Surg Pathol 1996; 20: 36-45.
115. Mayall F G, Gibbs A R. Pleural and pulmonary carcinosarcomas. J Pathol 1992; 167: 305-311.
116. Willen R, Bruce T, Dahlstrom G, Dubiel W T. Squamous epithelial cancer in metaplastic pleura following extrapleural pneumothorax for pulmonary tuberculosis. Virch Arch (A) Pathol Anat 1976; 370: 225-231.
117. Kwee W S, Veldhuizen R W, Golding R P, Donner R. Primary 'adenosquamous' mesothelioma of the pleura. Virch Arch (A) Pathol Anat 1981; 393: 353-357.
118. Briselli M, Mark E J, Dickersin G R. Solitary fibrous tumours of the pleura; eight new cases and review of 360 cases in the literature. Cancer 1981; 47: 2678-2689.
119. Carter D, Otis C N. Three types of spindle cell tumors of the pleura, fibroma, sarcoma, sarcomatoid mesothelioma. Am J Surg Pathol 1988; 12: 747-753.
120. England D M, Hochholzer L, McCarthy M J. Localized benign and fibrous malignant tumors of the pleura; A clinicopathologic review of 223 cases. Am J Surg Pathol 1989; 13:640-658.
121. Hint A, Weiss S. CD34 and keratin distinguishes solitary fibrous tumor (fibrous mesothelioma) from desmoplastic mesothelioma. Hum Pathol 1995; 26: 428-431.
122. Henderson D W, Attwood H D, Constance T J, Shilkin K B, Steele R H. Lymphohistiocytic mesothelioma; a rare variant of predominantly sarcomatoid mesothelioma. Ultra Pathol 1988; 12: 367-384.
123. Moran C A, Travis W D, Rosada-de-Christenson M et al. Thymomas presenting as pleural tumors: report of eight cases. Am J Surg Pathol 1992; 16: 138-144.